1. Home
  2. PMT vs CRVS Comparison

PMT vs CRVS Comparison

Compare PMT & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PennyMac Mortgage Investment Trust of Beneficial Interest

PMT

PennyMac Mortgage Investment Trust of Beneficial Interest

HOLD

Current Price

$10.13

Market Cap

884.2M

Sector

Real Estate

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$11.99

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMT
CRVS
Founded
2009
2014
Country
United States
United States
Employees
7
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
884.2M
1.0B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
PMT
CRVS
Price
$10.13
$11.99
Analyst Decision
Hold
Strong Buy
Analyst Count
5
6
Target Price
$13.50
$30.17
AVG Volume (30 Days)
851.9K
1.4M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
13.33%
N/A
EPS Growth
N/A
48.04
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.55
N/A
P/E Ratio
$12.59
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.83
$3.55
52 Week High
$13.80
$26.95

Technical Indicators

Market Signals
Indicator
PMT
CRVS
Relative Strength Index (RSI) 39.86 43.85
Support Level N/A $11.13
Resistance Level $12.76 $14.00
Average True Range (ATR) 0.23 0.63
MACD 0.04 0.15
Stochastic Oscillator 27.24 56.22

Price Performance

Historical Comparison
PMT
CRVS

About PMT PennyMac Mortgage Investment Trust of Beneficial Interest

PennyMac Mortgage Investment Trust is a specialty finance company that invests mainly in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: